Load- and quality-related comparison at mean annual flow conditions (WQS are exceeded only for diclofenac and PFOS)
| Substance . | Quality-related benefit . | Load-related benefit . |
|---|---|---|
| additional km with CF <1 (km) . | resulting in overall load reduction (g d−1) . | |
| Benzotriazole | 0 | −498 |
| Carbamazepine | 0 | −29 |
| Clarithromycin | 0 | −17 |
| Diclofenac | 118 | −21 |
| Sulfamethoxazole | 0 | −4.8 |
| Tolyltriazole | 0 | −165 |
| PFOS | 0 | −0.1 |
| TCPP | 0 | −38 |
| Substance . | Quality-related benefit . | Load-related benefit . |
|---|---|---|
| additional km with CF <1 (km) . | resulting in overall load reduction (g d−1) . | |
| Benzotriazole | 0 | −498 |
| Carbamazepine | 0 | −29 |
| Clarithromycin | 0 | −17 |
| Diclofenac | 118 | −21 |
| Sulfamethoxazole | 0 | −4.8 |
| Tolyltriazole | 0 | −165 |
| PFOS | 0 | −0.1 |
| TCPP | 0 | −38 |